Job Description
- Reporting direcrtly into the CFO
- At the cutting edge of an highly promising and dynamic clinical stage biotech
About Our Client
Our client is a global clinical stage biotechnology company focused on the development of innovative therapies addressing areas of high unmet medical need. With multiple near term clinical and regulatory milestones and a transition toward commercialization underway, the company is entering a critical phase of growth requiring enhanced engagement with the global investment community.
Job Description
Reporting directly to the Chief Financial Officer, the Director of Investor Relations will hold a highly visible and execution focused role during a pivotal period in the company evolution. This individual will be responsible for shaping and delivering a clear and differentiated investment narrative by translating complex scientific, clinical, and regulatory data into compelling messaging for institutional investors and sell side analysts. The role will act as a close partner to the CEO and CFO and will lead the full execution of the investor relations strategy. Main duties and responsibilities will include the following:
- Partner with the CEO and CFO to define and implement the investor relations strategy
- Serve as a primary point of contact for institutional investors, sell side analysts, and shareholders
- Own and continuously refine the investment thesis and equity story
- Lead day to day IR execution including earnings preparation, investor presentations, Q&A preparation, conferences, roadshows, and investor targeting
- Translate preclinical and clinical data, mechanisms of action, trial endpoints, statistical outcomes, safety profiles, and competitive positioning into clear investor focused messaging
- Support investor communications surrounding clinical readouts and regulatory milestones including submissions, advisory committees, and approvals
- Draft and coordinate scientific and financial content for investor decks, press releases, scripts, and IR website materials in alignment with finance, legal, and communications teams
- Build and maintain long term relationships with leading biotechnology investors and analysts
- Monitor peer companies, competitive landscape, clinical developments, regulatory changes, and sector trends
- Track analyst models, consensus expectations, and key valuation drivers, providing actionable insights to senior leadership
- Ensure all external communications comply with SEC and disclosure requirements including support for earnings releases and public filings
- Maintain ownership of IR infrastructure including website content, investor calendars, shareholder surveillance, and engagement analytics
- Support development of commercialization and launch related messaging in collaboration with commercial leadership
- Integrate scientific, clinical, financial, and commercial narratives into a cohesive and credible equity story
This is a pivotal role which requires regular travel to Europe, +/- 50% of the time. When not traveling, part of the role can be HYBRID and there is an office close to Waltham, MA. The Successful Applicant
In return for a competitive remuneration package, the successful candidate will possess the following:
- Bachelor's degree
- Advanced degree in some sort of Scientific field e.g. PhD, MD, or PharmD etc.
- MBA or equivalent finance training strongly preferred, CFA a plus
- 7+ or more years of relevant experience in investor relations, equity research, investment banking, or consulting within biotechnology or pharmaceuticals
- Strong understanding of clinical trial design, biostatistics, and FDA and EMA regulatory pathways
- Prior experience supporting public company disclosure and earnings cycles
- Proven ability to communicate complex scientific and clinical data to sophisticated investor audiences
- Strong understanding of biotechnology valuation drivers
- Executive presence with confidence engaging senior leadership and external stakeholders
- High attention to detail with strong cross functional collaboration skills
What's on Offer
- $ 280,000 to $ 300,000 base salary
- Performance related annual bonus scheme
- A highly visible leadership role within a rapidly evolving clinical stage biotech company
- Direct exposure to C suite leadership and board level stakeholders
- Opportunity to shape the market narrative through key clinical and commercial milestones
Contact
Tom Smith
Quote job ref
JN-042026-7005496
Job Tags
Permanent employment, Work at office